Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Osiris Therapeutics, Inc.    

OSIRIS THERAPEUTICS, INC.
Mes dernières consult.
Most popular
Report
 SummaryChartsNewsCalendarCompanyFinancials 
Company
Osiris Therapeutics, Inc. engages in stem cell research and development of pharmaceutical products.Its regenerative medicine targets dermal burns, pressure ulcers, venous leg, diabetic foot ulcers, as well as tissue and bone repair.The company was founded by Peter A. Friedli and James S. Burns on... 
Sector
Biotechnology & Medical Research
Calendar

- No events available -

More about the company
Latest news on OSIRIS THERAPEUTICS, INC.
10/23 Osiris Announces a Peer-Reviewed Publication of a Scientific Study Reporting ..
10/19 Osiris Therapeutics to Present 10 Advanced Clinical and Scientific Abstracts,..
10/05 Osiris Announces a Peer-Reviewed Publication Reporting the Use of Placental M..
06/26 Osiris Appoints Linda Palczuk to serve as its President & CEO
06/26 OSIRIS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial..
06/14 OSIRIS ANNOUNCES ELECTRONICALLY AVAI :   Open Surgical Implantation of a Viable ..
05/31 OSIRIS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial..
05/31 OSIRIS THERAPEUTICS : Appoints David White to its Board of Directors
05/19 OSIRIS THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
05/18 OSIRIS THERAPEUTICS, INC. : Changes in Registrant's Certifying Accountant (form ..
More news
Sector news : Bio Therapeutic Drugs
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval -- Update
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval
10/18DJACTELION : J&J Net Income Falls After Actelion Deal -- WSJ
10/17 Regeneron-Sanofi drug succeeds mid-stage study
10/17DJJOHNSON & JOHNSON : Outlook Buoyed by Drug Unit -- Update
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
10/11 MANNKIND : 2nd Short Opportunity
09/25 TACTILE SYSTEMS : Multiple Near-Term Catalysts For 75% Downside
03/28 Midday Gainers / Losers
03/28 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
03/21 After Hours Gainers / Losers
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | US68827R1086 | 4-Traders
Income Statement Evolution
Managers
NameTitle
Linda Palczuk President & Chief Executive Officer
Peter A. Friedli Chairman
Frank D. Czworka Chief Operating Officer
Linda L. Chang Chief Financial Officer
Alla Danilkovitch Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
OSIRIS THERAPEUTICS, INC.0.00%155
GILEAD SCIENCES13.41%106 054
REGENERON PHARMACEUTICALS17.95%46 395
VERTEX PHARMACEUTICALS109.90%38 985
ACTELION24.15%29 840
GENMAB13.21%12 865